Diabetes Canada is proud to announce the winners of its End Diabetes Awards, an annual competition that aims to improve the ...

The once-a-day semaglutide pill is approved for reducing the risk of heart disease and Type 2 diabetes, the company said in a statement Monday.

For diabetes researchers across Canada, data from patients is a critical tool in determining what projects will truly make a difference for people living with the disease. Understanding how many ...

An AI-powered lifestyle intervention app for prediabetes reduced the risk of diabetes similarly to traditional, human-led programs in adults in a recent study, researchers from Johns Hopkins Medicine ...